Population- based Surveillance of Reportable Diseases in Nursing Home Facilities in Nebraska Manjiri Joshi, MPH + Alison Keyser Metobo, MPH + + Epidemiology.

Slides:



Advertisements
Similar presentations
Methicillin resistant Staphylococcus aureus (MRSA) in the Nordic countries Petter Elstrøm Advisor Norwegian Institute of Public Health.
Advertisements

NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
From study objectives to analysis plan Helen Maguire.
HIV Epidemiology Program: Epidemiology of HIV and AIDS in Los Angeles County Presentation to Public Health Commission October 28, 2010 Douglas M. Frye,
Antimicrobial resistance surveillance in Ireland Results of invasive Staphylococcus aureus infection (blood) surveillance (2009Q1-4) **** Data as of 14/04/2010.
Comparability of Electronic and Manual Influenza-like Illness (ILI) Surveillance Methods Robin M. Williams, Nebraska Department of Health & Human Services/University.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Measurement: the why and the what
REALM project update MRSA and KPC January 26, 2011 Michael Lin, MD MPH on behalf of REALM co-investigators.
EPIDEMIOLOGY AND SURVEILLANCE Southwest Florida Disaster Healthcare Coalition June 13, 2014 Jennifer Roth, MSPH Director of Epidemiology Florida Department.
Unintentional Fall Injuries and Deaths Among MA Older Adults, Ages 65 Years and Over Carrie Huisingh, MPH, Epidemiologist Holly Hackman, MD, MPH, Epidemiologist.
Role of the laboratory in disease surveillance
Antimicrobial Resistance Surveillance Latin America
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
MRSA Barbara Kilian, MD St.Luke’s Roosevelt Academic Associate Program Fall 2005.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Epidemiology Modeling the Spread of Disease Designing and Running Experiments Modeling and Simulation Module 1: Lesson 5.
Methicillin-Resistant Staphylococcus aureus Infections in California Hospital Patients, 1999 – 2006 Mary Tran, PhD, MPH Niya Fong, BS Microbiology California.
Big Bad Bugs in the Dialysis Unit Douglas Shemin, MD Kidney Diseases and Hypertension Division, Rhode Island Hospital.
Skill Sets Sometimes Forgotten for Epidemiological Response Marilyn Felkner, DrPH, epidemiologist Infectious Disease Surveillance and Epidemiology Branch.
NOSOCOMIAL INFECTIONS Phase 1: Testing the efficacy of Nano-Mg (OH) 2 Dorothea A. Dillman PhD, RN, CCRN, LNC.
. Nosocomial Antibiotic Resistant Organisms Copyright © Texas Education Agency, All rights reserved.
Epidemiology Tools and Methods Session 2, Part 1.
CSI 101 Skills Lab 2 Standard Precautions Personal Protective Equipment (PPE) Daryl P. Lofaso, M.Ed, RRT.
Measurement: the why, the what, and the how Paula Griswold, MPH Executive Director Massachusetts Coalition for the Prevention of Medical Errors Nora McElroy,
USING UNDERREPORTING ESTIMATES TO MOBILIZE THE DEVELOPMENT OF TARGETED, PROACTIVE FOOD SAFETY POLICY Dr. Andrew Papadopoulos Coordinator, Master of Public.
Indiana Healthcare Associated Infection Initiative Kickoff.
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
Streptococcus pneumoniae Lecture 9 Summer, 2004 Demosthenes Pappagianis, MD MMI 480B.
Using and Sharing Findings from Surveillance: Rates, Ratios Proportions, Data Display & OUTBREAKS Russ Olmsted, MPH, CIC
Decreasing Incidence of Pertussis in Massachusetts Following the Introduction of Tdap Noelle Cocoros, Nancy Harrington, Rosa Hernandez, Jennifer Myers,
Maria del Rosario, MD, MPH Division of Infectious Disease Epidemiology WVDHHR/BPH/OEPS February
Illinois Healthcare-Associated Infections (HAI) Plan Mary Fornek January 21, 2010 Metropolitan Chicago Healthcare Council.
Community-acquired methicillin-resistant Staph. aureus (CA-MRSA): Amarillo experience Infectious Disease Epidemiology Work Group Texas Department of State.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005 By Samuel F. Barker, MT School of Rural Public Health Texas A&M Health Science Center.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
1 Local Jurisdiction’s Health Officer Order Mandating Influenza Vaccination of Healthcare Personnel in Los Angeles County: Preliminary Findings Jessica.
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
WISCONSIN STATE LABORATORY OF HYGIENE 1 Analysis and Comparison of Cumulative Statewide Antibiograms for Wisconsin, 2006 and 2008 Christina M. Carlson.
NOSOCOMIAL INFECTIONS
Vaccines and Related Biological Products Advisory Committee Meeting July 23, 2009 Novel influenza A (H1N1) Epidemiology Update Anthony Fiore, MD, MPH Influenza.
F UNCTIONAL L IMITATIONS IN C ANCER S URVIVORS A MONG E LDERLY M EDICARE B ENEFICIARIES Prachi P. Chavan, MD, MPH Epidemiology PhD Student Xinhua Yu MD.
Urban/Rural Differences in Survival Among Medicare Beneficiaries with Breast Cancer Melony E.S. Sorbero, Ph.D. RAND Corporation Funded by Health Resources.
Trends in Neisseria gonorrhoeae Incidence in Washington State Region X GC Meeting Trends in Neisseria gonorrhoeae Incidence in Washington State Region.
Michigan Disease Surveillance System Syndromic Surveillance Project January 2005.
Evaluation of Brucellosis Surveillance System in the West Bank - Palestine, June 2015 Huda Lahham, PharmD Palestinian Ministry of Health Funded.
Impact of Childhood Hepatitis A Vaccination: New York City Vikki Papadouka, PhD, MPH Jane R. Zucker, MD, MSc Sharon Balter, MD Vasudha Reddy, MPH Kristen.
Correlation of National Influenza Surveillance Data to the Local Experience Kate Goodin, MPH Florida Department of Health Bureau of Epidemiology 6 th Annual.
Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.
The Epidemiology of Varicella Disease in New York City, Janelle A. Anderson, MPH CDC/CSTE Applied Epidemiology Fellow New York City Department.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Epidemiological measureas. How do we determine disease frequency for a population?
Trends and Seasonal Patterns in Hospitalization Rates of Clostridium Difficile in the US Elderly Jyotsna S. Jagai, Sara M. Parisi, Meena P. Doshi, Elena.
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
CDC EIS Field Assignments Branch New Jersey Department of Health
Alison Keyser Metobo, MPH +
Mandating hospital and commercial
Improving SARI Surveillance in Saint Lucia
CSI 101 Skills Lab 3 Universal Precautions and
Maria del Rosario, MD, MPH Arianna DeBarr, RN, BSN
Sarah Siddiqui, MD, MPH University of Texas Medical Branch
Report Back Track 6: Population Health Track
Varicella Surveillance in Texas
Maryland HCW Influenza Vaccination Survey Highlights
National Immunization Conference
Presentation transcript:

Population- based Surveillance of Reportable Diseases in Nursing Home Facilities in Nebraska Manjiri Joshi, MPH + Alison Keyser Metobo, MPH + + Epidemiology Surveillance Response Coordinator

Overview Background – Nursing home increased risk for infection – Health outcomes in nursing home residents – Baseline for Nebraska cases Objective Methods – Estimated incidence rates in nursing home residents – Comparing estimated incidence rates in nursing home residents and non-nursing home cases Results Next Steps

Background

Nursing Home residents are at increased risk for infection – Advanced Age – Group Living – Comorbidities – Compromised Immunity – Need for hospitalization

Health outcomes for nursing home residents Clostridium Difficile infections Influenza Methicillin Resistance Staphylococcus Aureus Vancomycin resistance Enterococci

Compared Nebraska incidence rates with national incidence rates – Establish baseline in Nebraska population

revised reportable disease regulations implemented in Nebraska Conditions added for laboratories reporting via Automated Electronic Laboratory Reporting (ELR) Acinetobacter spp. Streptococcus pneumoniae Enterococcus spp. Influenza Klebsiella spp. Clostridium difficile Staphylococcus aureus Meningococcal disease, invasive (Neisseria meningitidis)

Objectives Calculate estimated incidence rates among nursing home residents for selected agents for 2010 ̶ 2011 Compare estimated incidence rates for nursing home residents and non-nursing home cases who are 65 years and older

METHODS

ELR (All Reportable Conditions) Nebraska’s Electronic Diseases Surveillance System (NEDSS) Different line lists with selected variables are created and exported as excel files HL-7 SAS Codes

Nursing home data “Nursing home associated case”- –any lab report where patient address = Nursing home address Obtained addresses of all 231 licensed Nursing home facilities Nursing home line list and 2011 Selected agents –Clostridium Difficile –Enterococcus Sp. –Influenza –Methicillin Resistant Staphylococcus Aureus (MRSA) –Non MRSA Staph –Streptococcus Pneumonia ** For influenza only positive cases were included

Non-nursing home data Lab report data (ELR) for 2010 ̶ 2011 Selected agents –Clostridium Difficile –Enterococcus Sp. –Influenza –Methicillin Resistant Staphylococcus Aureus (MRSA) –Non MRSA Staph –Streptococcus Pneumonia ** For influenza only positive cases were included

Estimated incidence rates for nursing home residents 2010 ̶ 2011 Total number of licensed beds in Nebraska were used as proxy for convenience as population at risk to calculate the estimated incidence rates in nursing home facilities * Proxy for population at risk Incidence Rate = Number of cases Number of licensed beds*

Compare estimated incidence rates for nursing home residents and non-nursing home cases Nursing home cases – Assumption : Majority of the population in nursing home was 65 years and above – All the licensed beds in Nebraska were used by this population Incidence Rate = Number of cases in nursing home who are 65 yrs and older Total number of licensed beds Non-nursing home cases – Number of cases for 65 years and above was included – Age specific population for Nebraska was used to calculate the incidence (Denominator) Incidence Rate = Number of cases who are 65 yrs and older Population at risk who are 65 yrs and older

RESULTS

Number and proportion of lab reports for which patient address was available YearTotalCount (n) % of available address % %

Number and proportion for Nursing homes in Nebraska identified in the Lab reports for 2010 and 2011 Total Number of Beds – 16,975 Median: 62 Range: Total # of Nursing homes in Nebraska # identified in 2010, 2011 Percentage %

Nursing home associated cases by age and gender and 2011 Total Statewide incidence Male Total % Female Total % % Missing gender inform. Age Median Age Range Clostridium Difficile Enterococcus Sp Influenza MRSA Non MRSA - Staphylococcus Aureus Streptococcus Pneumonia

Estimated incidence rates for nursing home residents using total number of licensed beds (16,975) in Nebraska

Estimated incidence rates: nursing home residents vs. non nursing cases (65 years and above)

Evaluation Chart Review – Validate number of nursing home cases

Next Steps Add question to the investigation: “ If you are a nursing home resident?” Nursing home survey – To get number of residents in each nursing home – Age and gender information

Limitation Total population in nursing homes Age specific information for nursing home cases Address information – No consideration for missing address

Acknowledgement Bryan Buss *, DVM, MPH, DACVPM Eryn Murphy ᴪ MS Tom Safranek **, MD * CDC Career Epidemiology Field Officer (CEFO), Nebraska Department of Health and Human Services ** State Epidemiologist, Nebraska Department of Health and Human Services ᴪ Epidemiology Syndromic surveillance Coordinator